Spencer Francis YoungSpencer FrancisYoung

Spectrum Pharmaceuticals, Inc., in its public offering of common stock, resulting in proceeds of $70.3 million

Kratos Defense & Security Solutions in its public offering of common stock, resulting in proceeds of $209 million

The Boeing Company in its acquisition of the EnCore Group

Secura Bio in its acquisition of the global rights to Farydak® (panobinostat) from Novartis

Secura Bio in its $145 million debt and equity financing led by Athyrium Capital Management, LP

Spectrum Pharmaceuticals, Inc., in its sale of seven FDA-approved hematology/oncology products for an upfront purchase price of $160 million and up to $140 million in contingent milestone payments

Genoptix, Inc. in the sale of the company to NeoGenomics, Inc. for $125 million in cash and one million shares of NeoGenomics, Inc. common stock

Teleperformance SE, a French public company, in its $1.0 billion acquisition of the Intelenet Group from Blackstone

Synergy One in its sale of the company to Mutual of Omaha Bank

Kratos Defense & Security Solutions, Inc., in its 144A notes offering

Kratos Defense & Security Solutions, Inc., in its public offering of common stock, resulting in proceeds of $186.0 million

A leader in case management cloud solutions in its Series B and Series C preferred stock financings

NCI, Inc., in the $283 million sale of the company to HIG Capital

Covisint Corporation in the $103 million sale of the company to OpenText

Kratos Defense & Security Solutions, Inc. in its public offering of common stock, resulting in proceeds of $81.6 million

Inseego, Corp. in its consent and exchange solicitation and $120 million public offering of senior convertible notes

Kratos Defense & Security Solutions, Inc. in its public offering of common stock, resulting in proceeds of $76.1 million